GGrantIndex
Sort

40,608 grants matching prostate cancer

Integrating targeted therapy and immunotherapy to break through cancer

$1,027,633
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2023 · CA

Clinical Pharmacogenetics

$1,027,532
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Patient-Derived Models of Prostate Cancer for Personalized Medicine

$1,026,019
Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA

CIP Genomics Core

$1,025,863
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

A genomewide study of lung cancer in never smokers

$1,025,637
Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA

MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation

$1,025,457
Aytekin Oto · Qmis, Llc · UT2 · FY2023 · CA

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research

$1,025,217
Catherine M. Tangen · Fred Hutchinson Cancer Center · U01 · FY2023 · CA

Risk Factors for Breast Cancer in Younger Nurses

$1,024,867
Walter C. Willett · Harvard School Of Public Health · R01 · FY2011 · CA

Transgenic Core Facility

$1,024,561
Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation

$1,024,503
Aytekin Oto · Qmis, Llc · UT2 · FY2022 · CA

Etiological Studies of Gastric Carcinoma

$1,024,383
Pelayo Correa · Vanderbilt University · P01 · FY2012 · CA

SUPPORT SERVICES FOR THE PLCO ETIOLOGIC&EARLY MARKER STUDIES (PLCO EEMS)

$1,024,263
Thomas Riley · Information Management Services, Inc. · N02 · FY2021 · CA

Redes En Accion::The National Hispanic/Latino Cancer Network Research Network

$1,024,234
Amelie G Ramirez · University Of Texas Hlth Science Center · U54 · FY2012 · CA

Upstate Carolina Community Clinical Oncology Program

$1,023,952
Spartanburg Regional Medical Center · U10 · FY2001 · CA

Assay development and screening for molecular targets and discovery

$1,023,768
Brice Wilson · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Modeling prostate cancer control: prevention, screening, treatment, followup care

$1,023,733
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA

Biospecimen procurement and tissue microarray manufacture for the CHTN

$1,023,730
Christopher A. Moskaluk · University Of Virginia · UM1 · FY2019 · CA

1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center

$1,023,664
Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA

First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development

$1,023,231
Rajesh Krishnan · Oncternal Therapeutics, Inc. · R44 · FY2022 · CA

2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

$1,023,148
Folakemi T Odedina · University Of Florida · U54 · FY2019 · CA

COMBINING ANDROGEN DEPRIVATION AND IMMUNOTHERAPY TO PREVENT PROGRESSION TO CASTRATION-RESISTANT PROSTATE CANCER

$1,022,588
Health Research, Inc. · · FY2019 · Defense Health Agency

Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer

$1,022,522
Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2025 · CA

Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial

$1,021,979
Kathryn H. Schmitz · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA

Comparative Biomedical Scientist Training Program

$1,021,229
Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2014 · CA

CHARACTERIZING AND TARGETING ANDROGEN RECEPTOR PATHWAY-INDEPENDENT PROSTATE CANCER

$1,021,105
Regents Of The University Of California, San Francisco, The · · FY2010 · Department of Defense